Validation of a clinical trial composite endpoint for patients with necrotizing soft tissue infections

摘要

OBJECTIVE: Our objective was to develop and validate a composite endpoint for patients with necrotizing soft tissue infections that incorporates: local tissue injury, systemic organ dysfunction, and mortality.